Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf Mounjaro is causing constipation and your weight loss has stalled at the same time, those two things are often connected. Constipation on tirzepatide is common, particularly when gastric emptying slows significantly — and when your gut is backed up, the number on the scales can hold steady or even rise for days, independently of fat loss. These are prescription-only medicines that require clinical assessment; a prescriber looks at the full picture before and during treatment. What follows explains the mechanism, how to tell a genuine plateau from constipation-related stalling, and when to contact a clinician.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates both GLP-1 and GIP receptors, two gut-hormone pathways involved in appetite signalling and blood-sugar regulation. One of the ways it works is by slowing gastric emptying: food moves through the digestive system more gradually, which extends the feeling of fullness. That slower transit time, however, extends all the way through the intestines, and for many people the result is less frequent bowel movements, sometimes noticeably so.
A question our prescribers hear most weeks is some version of: "I haven't lost anything this week, is the treatment working?" Often the honest answer is yes, but the scales are temporarily misleading. Stool has weight. A sluggish gut can add one to three kilograms of scale weight in some people, and that reading will not budge until things move. Fat loss can be happening underneath that number without showing up yet. Tracking waist measurement alongside scale weight gives a clearer signal when constipation is a factor.
This doesn't mean constipation should simply be tolerated. Persistent constipation is uncomfortable, can reduce appetite further than intended, and occasionally contributes to nausea. Addressing it directly is worth doing, both for comfort and so the scales reflect what's actually happening. Our overview of Mounjaro side effects sets this in context alongside the broader profile of what to expect.
Deciding which of these three things you're dealing with shapes what you do next. Constipation-related stalling tends to have a pattern: weight holds or ticks up slightly, you feel bloated or full without having eaten much, and bowel movements have become infrequent. Once regularity returns, the scales often drop noticeably over one to two days, sometimes more than the preceding week's "loss" suggested.
A genuine weight-loss plateau looks different. Bowel habits are roughly normal, you're not noticeably bloated, but weight has been flat for three or more weeks. Plateaus are a real feature of weight-loss treatment; the body adjusts its energy expenditure over time. They don't mean tirzepatide has stopped working, but they are a prompt to review food intake, protein adequacy, and activity levels with your prescriber or a dietitian.
A third scenario is dose-related: if the current dose is the lowest (2.5mg), appetite reduction may be modest because the starter strength is intended to build tolerance, not deliver the full therapeutic effect. Dose titration is a clinical decision. The full Mounjaro treatment page explains how titration works in practice.
If you're unsure which scenario applies, our team at contact can direct you to the right support, and your prescriber review is the place to work through the detail.
Several straightforward measures help most people. Hydration is the first: tirzepatide reduces thirst signals for some patients, so drinking enough plain water requires a bit of intention rather than just following hunger and thirst cues. Aim to sip consistently through the day rather than catching up in one go.
Fibre is the second lever, soluble fibre from oats, flaxseed, and pulses tends to work better than insoluble fibre (bran) when the gut is slow, because insoluble fibre can worsen bloating if transit is already sluggish. Movement also helps; even a 20-minute walk after eating supports gut motility when appetite suppression means you're sitting still more than usual.
If dietary and lifestyle changes aren't enough within a week or two, a pharmacist can advise on appropriate over-the-counter options. What you should not do is reduce your Mounjaro dose unilaterally to see if it helps, any dose change is a clinical decision. More detail on managing this specific side effect is in our guide on how to relieve constipation on Mounjaro, and the question of whether the medicine is the direct cause is covered in does Mounjaro cause constipation. If you want to understand more about how Mounjaro constipation develops and what to expect, our dedicated page covers the topic in full, and if you're wondering specifically about why Mounjaro is causing constipation for you, we explain the mechanisms behind it there too.
Most constipation on tirzepatide resolves with the steps above. Some situations need prompt clinical attention. Contact a doctor or 111 if you have severe abdominal pain, particularly pain that is constant rather than cramping, or that radiates to the back. This can indicate a more serious condition, including acute pancreatitis, which the MHRA flagged in its January 2026 Drug Safety Update on GLP-1 medicines as an infrequent but serious risk.
Also seek medical advice if you haven't had a bowel movement in more than five days, if you notice blood in your stool, or if vomiting has made it difficult to stay hydrated. Dehydration combined with reduced food intake can affect the kidneys, so don't wait to see whether it resolves on its own in these circumstances.
For anything that feels less urgent but is bothering you, the aftercare team is available seven days a week. If you haven't yet started treatment and want to understand whether tirzepatide suits your situation, check your eligibility with a free consultation, a prescriber reviews every application personally, the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.